Table 1. Demographic and clinical characteristics of the study sample.
Variable | n (%) | Range | Mean±SD |
---|---|---|---|
Age (years) | 22–79 | 47.1±12.3 | |
Gender | |||
Male | 33 (27) | ||
Female | 88 (73) | ||
Ethnicity | |||
Asian | 11 (9.1) | ||
White British/Irish/other | 95 (78) | ||
Black African/Caribbean/other | 15 (12) | ||
Relationship status | |||
Married/living with partner | 73 (60) | ||
Single/other | 48 (40) | ||
Disease duration (months) | 4–336 | 62.01±42 | |
Laterality of GO | |||
Bilateral | 101 (83) | ||
Unilateral | 20 (17) | ||
Laterality of planned surgery | |||
Bilateral | 79 (65) | ||
Unilateral | 42 (35) | ||
Treatment history | |||
Previous immunosuppressants | 58 (48) | ||
Previous radiotherapy | 18 (15) | ||
Previous eyelid or orbital surgery | 14 (12) | ||
Thyroid function | |||
Stable | 106 (88) | ||
Unstable | 15 (12) | ||
Visual acuity (LogMAR conversion)a | 0–2 | 0.1±0.4 | |
Superficial punctate keratopathy | 39 (32) | ||
Hydraulic orbital signs | 25 (21) | ||
Optic neuropathy | 15 (12) | ||
Diplopia | 62 (51) | ||
Marginal reflex distance 1 (mm)a | 1.5–13 | 5.9±2.1 | |
Marginal reflex distance 2 (mm)a | 4–11 | 6.7±1.4 | |
Exophthalmometry (mm)a | 15–33 | 23.7±2.7 | |
Asymmetry (mm) | 0–8 | 1.8±1.8 | |
Clinical activity score | 0–9 | 1.12±1.9 | |
Smokers | 38 (31) |
A worst eye analysis was conducted on these variables, based on the amount of proptosis.